All Medicines
Dr. Aditya Singh

Medically Reviewed By

Dr. Aditya Singh, MBBS, MD (Pharmacology)

Reg No: MCI-654321 • Verified Medical Reviewer

Other hematological agents

Adakveo

(crizanlizumab)

Uses, side effects, dosage information & price range

Novartis Europharm Limited

About this medicine

Adakveo is indicated for the prevention of recurrent vaso occlusive crises (VOCs) in sickle cell disease patients aged 16 years and older. It can be given as an add on therapy to hydroxyurea/hydroxycarbamide (HU/HC) or as monotherapy in patients for whom HU/HC is inappropriate or inadequate.

Common Substitutes & Alternatives

These medicines share the same salt composition or therapeutic category and can be used as substitutes under professional medical supervision.

PyrukyndComposition: mitapivatAgios Netherlands B.V.
Price on RequestView Details →
Icatibant AccordComposition: icatibantAccord Healthcare S.L.U.
Price on RequestView Details →
WaskyraComposition: etuvetidigene autotemcelFondazione Telethon ETS
Price on RequestView Details →
DawnzeraComposition: donidalorsenOtsuka Pharmaceutical Netherlands B.V.
Price on RequestView Details →
CasgevyComposition: exagamglogene autotemcelVertex Pharmaceuticals (Ireland) Limited
Price on RequestView Details →

Key Information

Salt / Composition

crizanlizumab

Category

Other hematological agents

Manufacturer

Novartis Europharm Limited

Need a doctor's consultation?

Don't self-medicate. Consult a doctor before taking any medicine.

Medical Disclaimer

This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before taking any medication. Prices are indicative and may vary. Do not start, stop, or change the dosage of any medicine without your doctor's approval.

Disclaimer:Content on this page is for informational purposes only. Do not consume prescription medication without a registered practitioner's direct oversight.